InnovAtlasMalaria No More
Technology and manufacturing company

ChromoLogic LLC

Develop

ChromoLogic develops multiple diagnostic solutions, including portable malaria diagnostics for settings with limited laboratory infrastructure.

1
Endemic countries
1
U.S. states
3
Products and programs
About

What they do

ChromoLogic develops multiple diagnostic solutions, including portable malaria diagnostics for settings with limited laboratory infrastructure.1,2,3 Its QuickMag device detects malaria-related hemozoin and is undergoing clinical testing, while CAPTIN-D is a portable molecular test being developed to detect and characterize malaria parasites as well as other tropical diseases.3 Its U.S. R&D is based in Monrovia, California, and both technologies are in the development stage.3

In the United States
Products and programs

In the field and in development

QuickMag1,3

Portable hemozoin-based malaria diagnostic and surveillance tool

CAPTIN-D2,3

Portable CRISPR-based molecular diagnostic

2025 NIH Phase II award supporting further CAPTIN-D development2,3
Where they work

Partnerships in 1 endemic country

Product testing
Malawi
Africa
  • Queen Elizabeth Central Hospital (Blantyre) · diagnostic validation of QuickMag and CAPTIN-D, in collaboration with Michigan State University3
U.S. partners

Who they work with in the United States

Sources

Where this comes from

  1. 1chromologic.com
  2. 2sbir.gov
  3. 3Confirmed by the organization